AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Zucomet GP 2mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Zuciya Lifesciences

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Zucomet GP 2mg/500mg Tablet SR

Diabetics utilizing the dual-action medication, Glimepiride/Metformin 2mg/500mg extended-release tablets, manage type 2 diabetes mellitus. This formulation effectively regulates blood glucose in adult patients. Administer this medication with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on blood sugar monitoring. Continuous use is crucial; abrupt cessation, without medical consultation, risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing a healthy diet, regular physical activity, and weight management as directed by your healthcare provider. Lifestyle modifications significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headaches, and tremors. Regular meals and readily available fast-acting glucose sources (e.g., sugary snacks or juice) are essential. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Patients with a history of cardiac disease should inform their physician before commencing treatment. Pregnant or lactating individuals require medical consultation prior to use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended by your physician.

Uses of Zucomet GP 2mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Zucomet GP 2mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; do not chew, crush, or divide it. Consume Zucomet GP 2mg/500mg Extended-Release tablets with food.

Common Side effects of Zucomet GP 2mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Zucomet GP 2mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Zucomet GP 2mg/500mg Tablet SR whole; do not damage the tablet by chewing, crushing, or breaking it. Administer this medication with food.

How Zucomet GP 2mg/500mg Tablet SR works:

Each Zucomet GP 2mg/500mg sustained-release tablet combines glimepiride, a sulfonylurea, and metformin, a biguanide, to manage blood sugar. Glimepiride stimulates the pancreas to release more insulin, thus reducing blood glucose levels. Metformin acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of alcohol and Zucomet GP 2mg/500mg SR tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Zucomet GP 2mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Patient consultation with their doctor is advised.

Breast feedingBreast feedingUNSAFE

Extended-release Zucomet GP 2mg/500mg tablets are contraindicated for breastfeeding mothers due to potential infant toxicity.

DrivingDrivingCAUTION

Impaired driving may result from excessively high or low blood glucose levels. Refrain from driving if you experience such symptoms.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Zucomet GP 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Zucomet GP 2mg/500mg SR tablets are contraindicated in individuals with severe kidney disease. Routine monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Zucomet GP 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consult your physician. A reduced starting dose is usually recommended for those with mild to moderate liver disease; the medication is contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Zucomet GP 2mg/500mg Tablet SR :

Should you forget a dose of Zucomet GP 2mg/500mg Tablet SR, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Zucomet GP 2mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Zucomet GP 2mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Zucomet GP 2mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these symptoms, discontinue Zucomet GP 2mg/500mg Tablet SR and seek immediate medical attention.
Zucomet GP 2mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Zucomet GP 2mg/500mg Tablet SR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Prolonged use of Zucomet GP 2mg/500mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Zucomet GP 2mg/500mg SR Tablets can cause low blood sugar (hypoglycemia), resulting in symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This risk increases with missed or delayed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Zucomet GP 2mg/500mg Tablet SR with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Zucomet GP 2mg/500mg Tabl...
61
MRP 71
14% off